EKF Diagnostics (LON:EKF) Sets New 1-Year Low – What’s Next?

EKF Diagnostics Holdings plc (LON:EKFGet Free Report) shares reached a new 52-week low on Wednesday . The stock traded as low as GBX 23 ($0.29) and last traded at GBX 23 ($0.29), with a volume of 322279 shares. The stock had previously closed at GBX 24 ($0.30).

EKF Diagnostics Price Performance

The company has a quick ratio of 1.77, a current ratio of 4.60 and a debt-to-equity ratio of 0.34. The stock has a market capitalization of £102.23 million, a price-to-earnings ratio of 21.40 and a beta of 0.57. The business’s 50 day simple moving average is GBX 25.89 and its 200-day simple moving average is GBX 27.02.

EKF Diagnostics Company Profile

(Get Free Report)

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

Recommended Stories

Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.